PubMed
open access
Anti-C2-mediated complement inhibition prevents disease in a rat passive transfer model of myasthenia gravis.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Characterizing and quantifying disease impacts of generalized myasthenia gravis (gMG) in the United States: insights from patient and caregiver interviews and surveys.#404196
- An Open-label, Dose-escalation Phase Ib Study of EA5 Injection in Adults With Anti-AChR Antibody-Positive Generalized Myasthenia Gravis#876868
- Cell type-specific Ca2+ signals govern mouse seminiferous tubule physiology / Justine Audrey Fischoeder, David Fleck, Jerome Schröer, Christopher Wiesbrock, Lina Kenzler, Christoph Weber-Hamacher, Ilian Schröder, Melissa Franke, Stefanie Kurth, Martin Tobias Strauch, Guiscard Seebohm, Dorit Merhof, Johannes Stegmaier, Naofumi Uesaka, Jennifer Spehr, Marc Spehr#780313
- Muscle regeneration failure may lead to clinical features of myopathy in anti-IgLON5 disease#449047
- IgE-Sensitized Mast Cells Release Extracellular Vesicles that Transfer IgE and Spread Allergic Sensitization.#396015
Record · ID 441088
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive